MedWatch

Danish growth company acquires three firms and gains 100 new employees under new ownership

The capital fund EQT has had wind in its sails after taking ownership of the validation and monitoring equipment firm Ellab, which provides products to the pharmaceutical and biotech industries.

Photo: Ellab / PR

Even though the Covid-19 pandemic has been an obstacle to financial development of the Danish company Ellab, it won't have a permanent impact on the business, which has been growing steadily for a number of years, says Ellab's CEO and President Peter Krogh on the firm's recent development, as the company's ownership moved from the capital investment fund IK Investment to a larger fund of the same kind, EQT, last year.

"In principle, we're maintaining the same strategy that we established under our former owner, but of course, now we have a major apparatus behind us and more know-how in terms of digitization, and furthermore, we have increased our investments in research and development," Krogh says on the EQT collaboration.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Related articles